Entity Details

Primary name YLAT1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9UM01
EntryNameYLAT1_HUMAN
FullNameY+L amino acid transporter 1
TaxID9606
Evidenceevidence at protein level
Length511
SequenceStatuscomplete
DateCreated2001-01-24
DateModified2021-06-02

Ontological Relatives

GenesSLC7A7

GO terms

Show/Hide Table
GOName
GO:0000821 regulation of arginine metabolic process
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0006865 amino acid transport
GO:0015174 basic amino acid transmembrane transporter activity
GO:0015179 L-amino acid transmembrane transporter activity
GO:0016323 basolateral plasma membrane
GO:0050900 leukocyte migration
GO:1990822 basic amino acid transmembrane transport

Subcellular Location

Show/Hide Table
Subcellular Location
Basolateral cell membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR002293 Amino acid/polyamine transporter IFamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
222700 OMIMLysinuric protein intolerance (LPI)A metabolic disorder characterized by increased renal excretion of cationic amino acid (CAA), reduced CAA absorption from intestine, and orotic aciduria. On a normal diet, LPI patients present poor feeding, vomiting, diarrhea, episodes of hyperammoniaemic coma and growth retardation. Hepatosplenomegaly, osteoporosis and a life-threatening pulmonary involvement (alveolar proteinosis) are also seen. Biochemically LPI is characterized by defective transport of dibasic amino acids at the basolateral membrane of epithelial cells in kidney and intestine. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00130 L-GlutamineDrugbanksmall molecule
DB08838 AgmatineDrugbanksmall molecule
DB13146 Fluciclovine (18F)Drugbanksmall molecule

Interactions

2 interactions

InteractorPartnerSourcesPublicationsLink
YLAT1_HUMAN4F2_HUMANBioGRID9878049 details
YLAT1_HUMANNED4L_HUMANBioGRID19664597 details